Philip Terpolilli - Prestige Consumer Director Relations

All Insiders . Germany . 
Stock . Prestige Consumer Healthcare . Stakeholders . Insider . Philip Terpolilli
PBV Stock  EUR 76.50  1.50  2.00%   

Insider

Philip Terpolilli is Director Relations of Prestige Consumer Healthcare
Phone914 524 6800
Webhttps://www.prestigebrands.com

Prestige Consumer Management Efficiency

The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1312 %, meaning that it generated $0.1312 on every $100 dollars invested by stockholders. Prestige Consumer's management efficiency ratios could be used to measure how well Prestige Consumer manages its routine affairs as well as how well it operates its assets and liabilities.
Prestige Consumer Healthcare has accumulated 1.48 B in total debt with debt to equity ratio (D/E) of 163.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Prestige Consumer has a current ratio of 2.12, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Prestige Consumer until it has trouble settling it off, either with new capital or with free cash flow. So, Prestige Consumer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Prestige Consumer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Prestige to invest in growth at high rates of return. When we think about Prestige Consumer's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Shunyan ZhuAlibaba Health Information
52
Katsumi YamasakaInformation Services Internatio
N/A
Ka ChunAlibaba Health Information
N/A
Tsuyoshi HirashimaInformation Services Internatio
N/A
Shinichi OganeInformation Services Internatio
N/A
Chun KwongAlibaba Health Information
N/A
Chun YanAlibaba Health Information
N/A
Masahiro YamaguchiInformation Services Internatio
N/A
Hirohisa IwamotoInformation Services Internatio
N/A
John HammStewart Information Services
N/A
Brian GlazeStewart Information Services
54
Shinichi UminoInformation Services Internatio
N/A
Hiroyuki HashidaInformation Services Internatio
N/A
Yanwu TuAlibaba Health Information
44
Isao OguraInformation Services Internatio
N/A
Akira KobayashiInformation Services Internatio
64
Ryoichi NawaInformation Services Internatio
66
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter healthcare products in North America, Australia, and internationally. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. PRESTIGE CONS operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 520 people. Prestige Consumer Healthcare (PBV) is traded on Frankfurt Exchange in Germany and employs 535 people.

Management Performance

Return On Equity0.13
Return On Asset0.0576

Prestige Consumer Leadership Team

Elected by the shareholders, the Prestige Consumer's board of directors comprises two types of representatives: Prestige Consumer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Prestige. The board's role is to monitor Prestige Consumer's management team and ensure that shareholders' interests are well served. Prestige Consumer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Prestige Consumer's outside directors are responsible for providing unbiased perspectives on the board's policies.
William PPool, Gen VP
Jeffrey Zerillo, VP Operations
Philip Terpolilli, Director Relations
Adel Mekhail, Ex Sales
Christine Sacco, Chief Officer
Mary Fritz, VP Affairs
Dean Siegal, Director Communications
Ronald Lombardi, Pres Chairman

Prestige Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Prestige Consumer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.13
Return On Asset0.0576
Profit Margin0.19 %
Operating Margin0.31 %
Current Valuation4.2 B
Shares Outstanding49.69 M
Shares Owned By Insiders0.82 %
Shares Owned By Institutions99.18 %
Price To Earning21.30 X
Price To Book1.87 X

Currently Active Assets on Macroaxis

VVisa Class A
SSentinelOne
GMGeneral Motors
MSFTMicrosoft
FFord Motor

Other Information on Investing in Prestige Stock

Prestige Consumer financial ratios help investors to determine whether Prestige Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prestige with respect to the benefits of owning Prestige Consumer security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY